Your session is about to expire
← Back to Search
Device
TearCare for Meibomian Gland Dysfunction (OLYMPIA Trial)
N/A
Recruiting
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group
Summary
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease. NOTE: All sites have been selected for this study. We are not seeking additional sites at this time.
Eligible Conditions
- Meibomian Gland Dysfunction
- Dry Eye Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Meibomian Gland Secretion Score
Tear Break-Up Time
Secondary study objectives
Conjunctival staining score
Corneal staining score
Eye Dryness Score
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TearCareExperimental Treatment1 Intervention
Subjects will have heat applied to the eyelids for 15 minutes followed by manual expression of the meibomian glands.
Group II: LipiFlowActive Control1 Intervention
Subjects will have heat and pressure applied to the eyelids for 12 minutes.
Find a Location
Who is running the clinical trial?
Sight Sciences, Inc.Lead Sponsor
13 Previous Clinical Trials
1,200 Total Patients Enrolled
1 Trials studying Meibomian Gland Dysfunction
350 Patients Enrolled for Meibomian Gland Dysfunction
Share this study with friends
Copy Link
Messenger